Guest guest Posted December 14, 2006 Report Share Posted December 14, 2006 Journal of Rheumatology December 2006 Editorial -------------------------------------------------------------------------------- " Why Are Only 50% of Courses of Anti-Tumor Necrosis Factor Agents Continued for Only 2 Years in Some Settings? Need for Longterm Observations in Standard Care to Complement Clinical Trials " : http://www.jrheum.com/subscribers/06/12/2372.html Not an MD I'll tell you where to go! Mayo Clinic in Rochester http://www.mayoclinic.org/rochester s Hopkins Medicine http://www.hopkinsmedicine.org Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.